vs
INTEST CORP（INTT）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是INTEST CORP的1.5倍（$47.7M vs $32.8M），INTEST CORP净利率更高（3.8% vs -4.8%，领先8.6%），INTEST CORP同比增速更快（-10.3% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $-1.6M），过去两年INTEST CORP的营收复合增速更高（4.9% vs -20.2%）
INTEST CORP是面向全球半导体产业的专业测试设备供应商，主营研发、生产及销售热管理系统、测试接口硬件、晶圆处理工具等产品，客户覆盖晶圆制造厂、芯片设计企业及汽车、工业电子等下游领域。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
INTT vs IRWD — 直观对比
营收规模更大
IRWD
是对方的1.5倍
$32.8M
营收增速更快
INTT
高出37.0%
-47.3%
净利率更高
INTT
高出8.6%
-4.8%
自由现金流更多
IRWD
多$76.1M
$-1.6M
两年增速更快
INTT
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.8M | $47.7M |
| 净利润 | $1.2M | $-2.3M |
| 毛利率 | 45.4% | — |
| 营业利润率 | 3.9% | 14.3% |
| 净利率 | 3.8% | -4.8% |
| 营收同比 | -10.3% | -47.3% |
| 净利润同比 | -17.4% | -200.9% |
| 每股收益（稀释后） | $0.10 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INTTIRWD
| Q4 25 | $32.8M | $47.7M | ||
| Q3 25 | $26.2M | $122.1M | ||
| Q2 25 | $28.1M | $85.2M | ||
| Q1 25 | $26.6M | $41.1M | ||
| Q4 24 | $36.6M | $90.5M | ||
| Q3 24 | $30.3M | $91.6M | ||
| Q2 24 | $34.0M | $94.4M | ||
| Q1 24 | $29.8M | $74.9M |
净利润INTTIRWD
| Q4 25 | $1.2M | $-2.3M | ||
| Q3 25 | $-938.0K | $40.1M | ||
| Q2 25 | $-503.0K | $23.6M | ||
| Q1 25 | $-2.3M | $-37.4M | ||
| Q4 24 | $1.5M | $2.3M | ||
| Q3 24 | $495.0K | $3.6M | ||
| Q2 24 | $230.0K | $-860.0K | ||
| Q1 24 | $662.0K | $-4.2M |
毛利率INTTIRWD
| Q4 25 | 45.4% | — | ||
| Q3 25 | 41.9% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 41.5% | — | ||
| Q4 24 | 39.7% | — | ||
| Q3 24 | 46.3% | — | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 43.8% | — |
营业利润率INTTIRWD
| Q4 25 | 3.9% | 14.3% | ||
| Q3 25 | -4.5% | 61.8% | ||
| Q2 25 | -3.3% | 53.2% | ||
| Q1 25 | -10.8% | -70.7% | ||
| Q4 24 | 5.7% | 34.8% | ||
| Q3 24 | 1.6% | 28.0% | ||
| Q2 24 | 1.0% | 26.5% | ||
| Q1 24 | 1.6% | 14.7% |
净利率INTTIRWD
| Q4 25 | 3.8% | -4.8% | ||
| Q3 25 | -3.6% | 32.8% | ||
| Q2 25 | -1.8% | 27.7% | ||
| Q1 25 | -8.7% | -90.9% | ||
| Q4 24 | 4.1% | 2.5% | ||
| Q3 24 | 1.6% | 4.0% | ||
| Q2 24 | 0.7% | -0.9% | ||
| Q1 24 | 2.2% | -5.6% |
每股收益（稀释后）INTTIRWD
| Q4 25 | $0.10 | $0.01 | ||
| Q3 25 | $-0.08 | $0.23 | ||
| Q2 25 | $-0.04 | $0.14 | ||
| Q1 25 | $-0.19 | $-0.23 | ||
| Q4 24 | $0.13 | $0.03 | ||
| Q3 24 | $0.04 | $0.02 | ||
| Q2 24 | $0.02 | $-0.01 | ||
| Q1 24 | $0.05 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.2M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $103.6M | $-261.8M |
| 总资产 | $151.3M | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INTTIRWD
| Q4 25 | $14.2M | $215.5M | ||
| Q3 25 | $16.2M | $140.4M | ||
| Q2 25 | $19.2M | $92.9M | ||
| Q1 25 | $22.0M | $108.5M | ||
| Q4 24 | $19.8M | $88.6M | ||
| Q3 24 | $18.0M | $88.2M | ||
| Q2 24 | $20.4M | $105.5M | ||
| Q1 24 | $27.3M | $121.5M |
总债务INTTIRWD
| Q4 25 | — | — | ||
| Q3 25 | $4.9M | $199.5M | ||
| Q2 25 | $5.9M | $199.3M | ||
| Q1 25 | $6.9M | $199.2M | ||
| Q4 24 | $7.9M | $199.0M | ||
| Q3 24 | $9.0M | $198.8M | ||
| Q2 24 | $10.0M | $198.6M | ||
| Q1 24 | $11.0M | $398.3M |
股东权益INTTIRWD
| Q4 25 | $103.6M | $-261.8M | ||
| Q3 25 | $101.9M | $-264.2M | ||
| Q2 25 | $102.6M | $-308.2M | ||
| Q1 25 | $99.4M | $-334.1M | ||
| Q4 24 | $99.8M | $-301.3M | ||
| Q3 24 | $100.4M | $-311.3M | ||
| Q2 24 | $99.5M | $-321.7M | ||
| Q1 24 | $99.3M | $-330.5M |
总资产INTTIRWD
| Q4 25 | $151.3M | $396.9M | ||
| Q3 25 | $148.3M | $396.1M | ||
| Q2 25 | $149.7M | $342.9M | ||
| Q1 25 | $148.0M | $327.2M | ||
| Q4 24 | $152.3M | $350.9M | ||
| Q3 24 | $158.4M | $389.5M | ||
| Q2 24 | $160.6M | $395.6M | ||
| Q1 24 | $159.5M | $438.8M |
负债/权益比INTTIRWD
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $74.6M |
| 自由现金流率自由现金流/营收 | -4.7% | 156.3% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.82× | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $127.0M |
8季度趋势，按日历期对齐
经营现金流INTTIRWD
| Q4 25 | $-1.0M | $74.6M | ||
| Q3 25 | $3.5M | $47.6M | ||
| Q2 25 | $-688.0K | $-15.1M | ||
| Q1 25 | $5.5M | $20.0M | ||
| Q4 24 | $2.6M | $15.2M | ||
| Q3 24 | $4.2M | $9.9M | ||
| Q2 24 | $-5.1M | $33.5M | ||
| Q1 24 | $2.1M | $45.0M |
自由现金流INTTIRWD
| Q4 25 | $-1.6M | $74.6M | ||
| Q3 25 | $3.1M | $47.6M | ||
| Q2 25 | $-1.1M | $-15.1M | ||
| Q1 25 | $5.3M | $19.9M | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.7M | $9.9M | ||
| Q2 24 | $-5.4M | $33.4M | ||
| Q1 24 | $1.7M | $44.9M |
自由现金流率INTTIRWD
| Q4 25 | -4.7% | 156.3% | ||
| Q3 25 | 11.8% | 39.0% | ||
| Q2 25 | -4.1% | -17.7% | ||
| Q1 25 | 19.9% | 48.4% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 12.4% | 10.8% | ||
| Q2 24 | -15.9% | 35.4% | ||
| Q1 24 | 5.8% | 60.0% |
资本支出强度INTTIRWD
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 1.6% | 0.0% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 1.1% | 0.1% |
现金转化率INTTIRWD
| Q4 25 | -0.82× | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | 6.74× | ||
| Q3 24 | 8.58× | 2.71× | ||
| Q2 24 | -22.13× | — | ||
| Q1 24 | 3.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTT
| Environmental Technologies | $8.3M | 25% |
| Semiconductor Market | $6.9M | 21% |
| Thermal Testing Products | $6.4M | 19% |
| Service And Other Products | $4.8M | 15% |
| Oem Integrators And Distributor | $3.5M | 11% |
| Semiconductor Production Test Products | $3.0M | 9% |
IRWD
暂无分部数据
